---
title: "Why Shattuck Labs stock soared in December"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/271602890.md"
description: "Buttressed by a significant amount of fresh capital, the company is showing progress in the early development of its top investigational drug."
datetime: "2026-01-06T04:42:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/271602890.md)
  - [en](https://longbridge.com/en/news/271602890.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/271602890.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/271602890.md) | [繁體中文](https://longbridge.com/zh-HK/news/271602890.md)


# Why Shattuck Labs stock soared in December

Buttressed by a significant amount of fresh capital, the company is showing progress in the early development of its top investigational drug.

### Related Stocks

- [Shattuck Labs, Inc. (STTK.US)](https://longbridge.com/en/quote/STTK.US.md)

## Related News & Research

- [Why Shattuck Labs stock soared more than 53% higher this week](https://longbridge.com/en/news/278178348.md)
- [The quiet resurgence of plant-based illicit drugs](https://longbridge.com/en/news/278733066.md)
- [20:00 ETPRISM BioLab and Receptor.AI Announce Drug Discovery Collaboration Agreement](https://longbridge.com/en/news/278957605.md)
- [Legend sloughs off Carvykti threat from J&J's Tecvayli](https://longbridge.com/en/news/278925660.md)
- [09:45 ETMedical Knowledge Group Appoints David Margines to Board of Directors, Advancing Its Legacy in AI- and Analytics-Driven Drug Commercialization](https://longbridge.com/en/news/278896967.md)